Mcl-1 is classified as an antiapoptotic protein that is overexpressed in many types of IL-6-treated cancer cells, including prostate cancer, myeloma, gastric cancer, and cholangiocarcinoma cells, but not in control cells [34]. This evidence concerns the gene MCL1 and Familial prostate cancer.